1)Yano T, Kasai H, Horimatsu T, et al. A multicenter phase II study of salvage photodynamic therapy using talaporfin sodium(ME2906)and a diode laser(PNL6405EPG)for local failure after chemoradiotherapy or radiotherapy for esophageal cancer. Oncotarget 8:22135-22144, 2017
2)Oyama T, Monma K. A new classification of magnified endoscopy for superficial esophageal squamous cell carcinoma. Esophagus 8:247-251, 2011.
3)Hatogai K, Yano T, Kojima T, et al. Local efficacy and survival outcome of salvage endoscopic therapy for local recurrent lesions after definitive chemoradiotherapy for esophageal cancer. Radiat Oncol 11:31, 2016
4)Kagawa T, Ishikawa S, Inaba T, et al. Clinicopathological examination of ESD as salvage therapy for esophageal cancer after definitive chemo-radiation therapy. Endosc Int Open 6:E450-461, 2018
5)Nakajo K, Yoda Y, Hori K, et al. Technical feasibility of endoscopic submucosal dissection for local failure after chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma. Gastrointest Endosc 88:637-646, 2018
6)Ishihara R, Arima M, Iizuka T, et al. Endoscopic submucosal dissection/endoscopic mucosal resection guidelines for esophageal cancer. Dig Endosc 32:452-493, 2020
7)Nagami Y, Ominami M, Sakai T, et al. Repeated endoscopic submucosal dissection for esophageal neoplasia located close to a previous endoscopic submucosal dissection scar. Clin Transl Gastroenterol 11:e00226, 2020
8)Tamaoki M, Yokoyama A, Horimatsu T, et al. Repeated talaporfin sodium photodynamic therapy for esophageal cancer:safety and efficacy. Esophagus 18:817-824, 2021
9)Yamashita H, Kadota T, Minamide T, et al. Efficacy and safety of second photodynamic therapy for local failure after salvage photodynamic therapy for esophageal cancer. Dig Endosc 34:488-496, 2022